O'Dowd Sarah A 4
4 · Protagonist Therapeutics, Inc · Filed May 27, 2022
Insider Transaction Report
Form 4
O'Dowd Sarah A
Director
Transactions
- Award
Stock Option (right to buy)
2022-05-26+20,000→ 20,000 totalExercise: $8.31Exp: 2032-05-26→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The stock option vests in full on the earlier of (i) May 26, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service with the Issuer through such date.